Engaging Thought Leadership
Over 120 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
Biologics US 2024
03 - 04 October 2024 | San Diego, CA
Driving the discovery & development of safe, effective & innovative biologic drugs through streamlined discovery, clinical and analytical strategies
Biologics US 2024
Meet Our Expert Speakers
Biologics US 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Below are some of our featured speakers:
Amita Datta-Mannan
Associate Vice President,
Eli Lilly
Hans van der Vliet
CSO,
LAVA Therapeutics
Lauren Goodrich
Vice President,
Nimble Therapeutics
Matt Chu
Director,
Astellas Pharma US
Natalie Grinshtein
Director, ADC discovery,
Pfizer
Nazneen Dewji
CEO,
Cenna Biosciences Inc.
Olivier Kitten
Chief Executive Officer,
Affilogic
Robert Lutz
cso,
Iksuda Therapeutics
Suk Hyung
Senior Principal Scientist,
Genentech
Yi Xing
Senior Director,
Seismic Therapeutic
Alan Wahl
CEO,
Abacusbioscience
Aming Zhang
Head of AD and QC,
Pyxis Oncology
Andrew Vendel
Senior Director, Immunology,
Eli Lilly
Brandon Coyle
Associate director,
Gilead Sciences
Brian Avanzino
Principal Scientist,
Amgen
Brian Hall
Head of US Biologics Characterization, Expression and Purification,
Sanofi
Chris Hart
CEO,
Creyon Bio
Daniel Kirchhofer
Senior Fellow,
Genentech Inc.
Denise Steckel
Head of Clinical Collaborations Development,
Genentech
Jack Ostrowski
Director Protein Science,
Avidity Biosciences
Jan Schnitzer
Chief Executive Officer,
Proteogenomics Research Institute for Systems Medicine
Jay Jones
Scientist,
Pfizer
Jean Ge
Patent Attorney,
Wolf Greenfield
.jpg?length=600&name=130dd890-954d-47a2-adba-3ca27c4a7514-2-11764368speaker_photo-ESPHARMA-JEFF-LEYTON-127(4x4).jpg)
Jeffrey Leyton
Associate Professor,
University of Ottawa
Jinquan Luo
Director,
Johnson & Johnson
Julie Beaudet
CMC Sr. Staff Scientist,
Regeneron Pharmaceuticals
Kim Janda
Professor,
The Scripps Research Institute
Li Feng
Partner,
Finnegan
Lian Yi
Principal Scientist,
Genentech
Linda Horner
Chief Administrative Patent Judge,
United States Patent and Trademark Office
Madhura Deshpande
Principal Scientist,
Bristol Myers Squibb
Maria Hedlund
Principal Scientist, Toxicology,
Avidity Biosciences
Melissa Schutten
Senior Director,
Pfizer
Michael Cochran
Director, Chemistry,
Avidity Biosciences
Michael McPherson
Research Fellow,
AbbVie
Michael Sierks
Professor,
Arizona State University
Mike Schopperle
CEO,
CureMeta
Mimmi Ballard
Director, ADQC, Bioassays,
Vir Biotechnology
Nathan Alves
Associate Professor / Director of Translational Research,
Indiana University School of Medicine
Paul Richardson
Director Discovery Chemistry,
Pfizer Ltd
Philip Kim
Professor,
University of Toronto
Purbasa Patnaik
Associate Director,
Exelixis
Rajika Perera
Chief Executive Officer,
Poseidon LLC
Ramana Doppalapudi
Vice President, Chemistry,
Avidity Biosciences
Sasha Ebrahimi
Principal Investigator and Associate Fellow,
GSK
Steven Ballet
Professor,
Free University Brussels
Sylvia Yip
Intellectual Property Counsel,
Zentalis Pharmaceuticals
Udaya Rangaswamy
Director, Translational Biology,
Rondo Therapeutics
Wei Wang
Professor,
UC San Diego Health
Yang Su
Associate Director, Oncology (ADC Biology),
Bristol Myers Squibb
Yuan Cheng
Director,
Amgen
Meet Our Esteemed Sponsors
Gold Sponsors
Ajinomoto
Gold Sponsor
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India, providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including Corynex® protein expression technology, AJIPHASE® oligonucleotide synthesis, ADC, HPAPI, biocatalysis, continuous flow manufacturing and more.
TA Instruments - Waters LLC
Gold Sponsor
TA Instruments, a division of Waters Corporation, is a world leader in manufacturing innovative and reliable instruments that contribute to groundbreaking discoveries in medicine, materials science, and other scientific areas devoted to improving our world. TA Instruments recognizes that large molecule biochemists require simple, sensitive, and reproducible assays to elucidate biomolecular structures and functions. We offer a comprehensive set of 21 CFR Part 11 compliant solutions that are essential for ensuring desired product quality and guaranteeing safety and efficacy in the biopharmaceutical industry. Our technical support group is located in 24 countries across the globe and are available by phone or email to help you achieve your research goals.
Silver Sponsors
.jpg?length=600&name=d1c96ae7-8a06-4a91-94a8-7c4c134bcaf0-2-5668375logo-peg240500-abzena-plc-companyLogo-(2).jpg)
Abzena
Silver Sponsor
Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.
Alloy Therapeutics
Silver Sponsor
Alloy Therapeutics accelerates the drug discovery process by providing access to best-in-class foundational drug discovery platforms, services, and company creation capabilities. Alloy Therapeutics has developed novel strains for fully human antibody discovery and created innovative technology to support a multitude of modalities that can help to quickly identify candidates. Leveraging our world class scientists, Alloy therapeutics platforms and services enables you to build a more robust antibody-based therapeutic pipeline.
DelSiTech
Silver Sponsor
DelSiTech is the leader in using and developing biodegradable, amorphous silica (SiO2) matrix and sol-gel encapsulation technologies in drug delivery. The applicability of Silica Matrix technology is widespread. Silica matrix technology enables parenteral drug delivery routes such as subcutaneous, intramuscular, intraocular, and topical delivery, among many others. In addition, the therapeutic indications that the company is working on include metabolic diseases, musculoskeletal diseases, infectious diseases, oncology, and pain. DelSiTech's Silica Matrix technology can deliver a wide range of therapeutic agents, from poorly soluble small molecules to large biologics, over an extended period. The Silica Matrix is fully biodegradable, ensuring true controlled release and can enable stabilization of drug substances. With Silica Matrix technology, stable release profiles can be customized to last from days to a year, with minimal initial burst release.
MaxCyte
Silver Sponsor
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative, cell-based research. MaxCyte builds best-in-class technology designed to facilitate complex engineering of a wide variety of cells and to drive the rapidly expanding cell therapy market forward. For over 20 years, MaxCyte has been a leader in developing transfection workflows and ventures beyond today’s processes to innovate tomorrow’s solutions. MaxCyte is headquartered in Rockville, Maryland’s I-270 Biotech Corridor. To learn more, please visit www.maxcyte.com.
PipeBio
Silver Sponsor
PipeBio is an integrated cloud platform for no-code, end-to-end bioinformatic workflows for therapeutic antibody and biologics discovery. Used by both wet-lab scientists and bioinformaticians, the PipeBio platform features a powerful set of tools for sequence analysis and advanced visualizations. PipeBio allows creation of automated and standardized sequence analysis pipelines.
Sciex
Silver Sponsor
As part of the Danaher family of global life science and technology innovators, SCIEX continue to pioneer robust solutions in capillary electrophoresis and mass spectrometry. Our unique technologies enable scientists to achieve comprehensive characterization and sensitive quantification of various modalities, including protein therapeutics, cell & gene therapies, in simple and complex biological matrices. But we don’t just develop products. It is what we do together with our customers that sets us apart. That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust better inform critical decisions. Decisions that positively impact lives. We proudly stand behind our tagline: The Power of Precision.
Sphere Fluidics
Silver Sponsor
Sphere Fluidics is the Cambridge (UK)-based microfluidics tools company with a range of novel cell encapsulation products for single-cell analysis and isolation. The Sphere Fluidics proprietary picodroplet microfluidic technology platform is designed specifically for single-cell screening and isolation, allowing users to encapsulate and analyze single cells within a droplet while maintaining viability. Flagship product Cyto-Mine® provides an integrated system with the ability to select, manipulate, analyze, and isolate cells, through an easy to use and intuitive interface that can automatically screen up to 40 million cells in a matter of hours. This unrivaled throughput aids in the acceleration of biopharmaceutical discovery and development, cell therapy, and synthetic biology workflows, easing the journey of discovery in labs globally.
Bronze Sponsors
Cradle Bio B.V.
Bronze Sponsor
Cradle performs ML-guided lead optimization, helping R&D teams hit their protein engineering goals 1.5-12x faster. Our intuitive software platform enables scientists to easily work with state-of-the-art generative machine learning and offers different levels of control depending on the user's ML expertise. Cradle's models can optimize multiple properties across a range of modalities, and grow more powerful with every round of experimental data you upload. Models trained on your data are entirely private to you and you retain full IP over the sequences generated. Cradle only charges a flat annual subscription fee for access to its protein engineering platform. We are proud to partner with leaders including Novo Nordisk, Johnson & Johnson, Grifols and Twist Biosciences.
GeneFrontier
Bronze Sponsor
We are providing a unique platform technology named PUREfrex®, which is a fully reconstituted (or rebuilt) cell-free protein expression system. It's easy to customize the system for various applications at the molecular level. It has been widely used not only for the expression of difficult-to-express proteins, including therapeutic biologics, but also as a platform for high-throughput expression or in vitro display, which works synergistically with the AI/ML platform. We are exploring the potential of cell-free technologies in biologics.
.png?length=600&name=73739cc8-e311-4fbb-a7dd-68ee123f5d12-2-5668375logo-1.GenScriptCorporation_Logo_EN_Horizontal_FullColor-(2).png){kind=logo}
GenScript
Bronze Sponsor
GenScript Biotech Corporation (HK.1548) is a world leader in technologies and services for life science R&D and manufacturing. Built upon its solid DNA synthesis technology, the company comprises four major business units: a life-science services and products business unit, a biologics contract development and manufacturing organization (CDMO) business unit, an industrial synthetic products business unit, and an integrated global cell therapy company. GenScript accelerates scientific discovery and therapeutic breakthroughs with its customers. Since its founding in New Jersey, USA in 2002, GenScript has expanded its operations to serve more than 200,000 customers across 100 countries with a dedicated team of 6,900 employees. As of December 31, 2023, 87,700 peer-reviewed journal articles worldwide had cited GenScript ’s services and products. Guided by its mission to make people and nature healthier through biotechnology, GenScript strives to become the most trustworthy biotech company in the world. For more information, please visit GenScript Biotech's official website https://www.genscript.com
NOF CORPORATION
Bronze Sponsor
NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's lipid nanoparticle platform for nucleic acid delivery composed of COASOMEⓇ SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF LNP platform is becoming adopted in clinical planning by NOF collaborators.
Unchained Labs
Bronze Sponsor
Here’s the deal. We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it. Unleashing problem-tackling solutions that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
Network & Programme Sponsors
Biointron Biological USA Inc.
Network & Programme Sponsor
Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies. Biointron holds a leading position in the antibody expression service industry. From gene sequence to purified antibodies, our production only takes 2 weeks. We have delivered tens of thousands of recombinant antibodies for more than 1,800 biotech and pharma companies worldwide. Contact us: +1(732)790-8340, or info@biointron.com. Visit our website: www.biointron.com
evitria AG
Network & Programme Sponsor
Evitria AG is a Swiss-based global leader in transient expression and purification services of antibodies and proteins. We provide expert guidance in antibody, bispecific and multispecific development with HT screening production, optimized purification approaches, and novel technologies to explore. Our fourteen-year history with >130,000 successful protein production runs highlights a rapid and reliable platform, and we are excited to share this with the community in-person at Biologics US 2024.
Formulatrix
Network & Programme Sponsor
FORMULATRIX® collaborates with researchers to simplify the preparation and analysis of proteins and nucleic acids by designing solutions without boundaries and bringing cutting-edge technology to the life science industry. We supply software and laboratory automation solutions to the top pharmaceutical companies and leading academic research institutions working in a variety of genomics and proteomics applications. We are committed to researchers, labs, and to the scientific discoveries that will improve the lives of generations to come.
Nicoya
Network & Programme Sponsor
Nicoya is a pioneering company at the forefront of democratizing scientific exploration through groundbreaking advancements in microfluidics and nanotechnology. Committed to making cutting-edge label-free surface plasmon resonance (SPR) technology accessible to scientists across disciplines, Nicoya specializes in miniaturizing biomolecular binding analysis, with the aim to simplify experiments by automating user operation, reducing sample sizes by more than 100-fold, and eliminating bulky and complex instrumentation, ultimately providing researchers with cost-effective and easy-to-use tools. At Nicoya, our commitment to making technology more accessible drives us to empower scientists globally, fostering a new era of exploration and innovation.
Quantum-Si
Network & Programme Sponsor
Quantum-Si, The Protein Sequencing Company™, has a mission to make protein sequencing and analysis available to all scientists so that every lab, everywhere can better understand the role of proteins in cell biology and disease and use this knowledge to transform the world we live in. QSI brings the groundbreaking power of single-molecule proteomics with the first-to-market Next-Generation Protein Sequencer™, Platinum® and a straightforward workflow, space-saving benchtop instrument, and the power to precisely detect protein variants and modifications.
Selvita
Network & Programme Sponsor
Selvita Group has broad expertise and track record in oncology, inflammation, fibrosis, anti-infectives, respiratory diseases and CNS. The company offers drug discovery support at every stage of the early discovery phase up to the preclinical development. Selvita specializes in a variety of drug discovery processes from in silico drug design and synthesis of a target-focused library, SAR and ADME-driven lead optimization and toxicity prediction, followed by complex preclinical in vitro and in vivo pharmacology, structural biology, all tailored to the customer’s needs.
SGS Vitrology
Network & Programme Sponsor
SGS is the world’s leading inspection, verification, testing and certification company. With more than 90,000 employees, SGS operates a network of over 1,500 offices and laboratories around the world. The Life Science division serves pharmaceutical, biopharmaceutical, and medical device companies along the entire drug development pathway. With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products. SGS Vitrology provides a comprehensive range of biosafety services such as: virology, cell and molecular biology as well as microbiology and electron microscopy. Health Authorities, including the US FDA and the EMA, require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses, and other potential contaminants. SGS Vitrology helps clients by ensuring product safety in satisfying these regulatory requirements. Our GLP/GMP facility is MHRA certified, and US FDA audited.
Absci to Collaborate with the Memorial Sloan Kettering Cancer Center to Develop Biologics using AI
The two organisations will work side by side on up to six programmes which will develop new cancer drug candidates using AI.
RSC 'Emerging Technologies' Award Goes to Solid Phase Peptide Synthesis Group
The novel peptide synthesis protocol allows the synthesis of multiple peptide fragments on a single bead.
FDA Fast Track ADC for Patients with Triple Negative Breast Cancer
The fast track designation means that the clinical development and regulatory milestones of the drug candidate are likely to progress much faster.
GSK Buys CureVac's mRNA Vaccine Business Providing Welcome Cash Injection
CureVac will continue to build its R&D pipeline while allowing GSK to develop and commercialise a handful of its prophylactic mRNA vaccines.
2002 Nobel Prize for Chemistry: Kurt Wüthrich, Using NMR to Determine the 3D Structure of Proteins
Kurt Wüthrich, joint winner of the 2002 Nobel Prize for Chemistry, contributed to the use of NMR to discover the 3D structure of proteins using sequential assignment and mathematical techniques.
Looking Back on the 2002 Nobel Prize for Chemistry: Mass Spectrometry for the Analysis of Proteins
2002's Nobel Prize for Chemistry recognised the translation of mass spectrometry to large molecules which has been instrumental in unlocking the proteome toward new therapies.
The Westin San Diego Gaslamp Quarter
910 Broadway Circle
San Diego, 92101
California
United States
The Westin San Diego Gaslamp Quarter sits in the heart of the city's excitement, located near the Gaslamp quarter home to over 150 restaurants, cafes, bars, and shops. The Westin is also steps away from the San Diego Convention centre, Little Italy and Pecto Park. Within a 10 minute drive, you can also explore nearby beaches and attractions at the San Diego Zoo, Mission Beach's Belmont Park and SeaWorld San Diego.
By Air:
San Diego International Airport – The Westin San Diego Gaslamp Quarter is approximately 2 miles from the international airport. A taxi to and from the airport would cost around $12 - $15 and would take around 5-10 minutes depending on traffic.
The Westin San Diego offers airport transportation from 5am-11pm – please contact the hotel directly for more information about this.
By Train:
The closest train station to the venue is Santa Fe Depot which is roughly a 10-minute walk away. The North Country Transit is approximately a 10 min drive away. Please use the directions from the train station to direct yourself to the hotel.
By Bus:
The closest bus station to the hotel are Broadway & Union St and Broadway & 2nd Av which are a 2 min walk away.
Parking:
Parking is available at the hotel, with electric car charging stations at a daily parking valet of $60.00. Underground parking valet only USD 10 per hour or USD 60 overnight. Please note the garage height clearance is 8 feet. Please visit the hotel’s website for more information.
Oxford Global has secured a number of bedrooms at the The Westin San Diego Gaslamp Quarter at a reduced conference rate:
- Wednesday 2nd October 2024 – $315 (includes room rate & taxes)
- Thursday 3rd October 2024 – $315 (includes room rate & taxes)
Should you wish to book a room, please click here
The final cut-off date to book bedrooms is Wednesday 11th September 2024 – any bookings after this date are subject to availability and rates. Please note, that any cancellations within 14 days prior to arrival are subject to cancellation charges.
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Biologics US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.
